MarketWatch

Nastech responds to FDA on calcitonin-salmon nasal spray

SAN FRANCISCO (MarketWatch) -- Nastech Pharmaceutical Co. said Friday it has submitted a response to the Food and Drug Administration's office of generic drugs regarding the potential for ...
Houston Chronicle

(PRN) Nastech Announces Presentation of Scientific Abstracts at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting

Study Demonstrating that Nastech's Calcitonin-Salmon Nasal Spray is Bioequivalent to Novartis' Miacalcin(R) (Calcitonin-Salmon) Nasal Spray and The abstract presented data from a 199 subject trial ...
Medscape

Oral Salmon Calcitonin Superior to Nasal Formulation, Placebo

September 23, 2011 (San Diego, California) — Oral recombinant salmon calcitonin tablets are more effective at improving lumbar spine bone mineral density (BMD) after 48 weeks than placebo or a nasal ...
Reuters

FDA staff say calcitonin salmon cancer risk appears plausible

(Reuters) - Staff reviewers for the U.S. Food and Drug Administration said that a potential increased risk of cancer with drugs containing calcitonin salmon appears plausible. In briefing documents ...